Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer
2018 ◽
Vol 44
(6)
◽
pp. 760-765
◽
2021 ◽
2013 ◽
Vol 131
(2)
◽
pp. 437-444
◽